These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6249077)

  • 1. Enkephalin inhibition of adenylate cyclase activity in neuroblastoma N18TG2 cells: effect of sulfatide incorporation.
    Law PY; Nicksic TD; Loh HH
    Adv Biochem Psychopharmacol; 1980; 22():291-304. PubMed ID: 6249077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of opiate action in neuroblastoma N18TG2 cells by lipid incorporation.
    Law PY; Nicksic TD; O'Rourke MA; Koehler JE; Herz A; Loh HH
    Mol Pharmacol; 1982 Mar; 21(2):492-502. PubMed ID: 6285174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
    Law PY; Bergsbaken C
    J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of opiate inhibition of adenylate cyclase activity in neuroblastoma N18tG2 and neuroblastoma x glioma NG108-15 hybrid cell lines.
    Law PY; Koehler JE; Loh HH
    Mol Pharmacol; 1982 Mar; 21(2):483-91. PubMed ID: 6285173
    [No Abstract]   [Full Text] [Related]  

  • 5. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    Prather PL; Tsai AW; Law PY
    J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
    Law PY; Loh HH
    Mol Pharmacol; 1993 May; 43(5):684-93. PubMed ID: 8388986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling of prostaglandin E1 receptors to the stimulatory GTP-binding protein Gs is enhanced in neuroblastoma x glioma (NG108-15) hybrid cells chronically exposed to an opioid.
    Ammer H; Schulz R
    Mol Pharmacol; 1993 Apr; 43(4):556-63. PubMed ID: 8386308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of enkephalin activity in neuroblastoma X glioma NG108-15 hybrid cells by phospholipases.
    Law PY; Griffin MT; Koehler JE; Loh HH
    J Neurochem; 1983 Jan; 40(1):267-75. PubMed ID: 6294248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of receptor-mediated inhibition of adenylate cyclase in NG108-15 neuroblastoma X glioma cells by n-ethylmaleimide.
    Smith MM; Harden TK
    J Pharmacol Exp Ther; 1984 Feb; 228(2):425-33. PubMed ID: 6319678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
    Law PY; Hom DS; Loh HH
    Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioids, noradrenaline and GTP analogs inhibit cholera toxin activated adenylate cyclase in neuroblastoma x glioma hybrid cells.
    Propst F; Hamprecht B
    J Neurochem; 1981 Feb; 36(2):580-8. PubMed ID: 6257856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells.
    Carter BD; Medzihradsky F
    Mol Pharmacol; 1993 Mar; 43(3):465-73. PubMed ID: 8383804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
    Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of opiate receptor activity in neuroblastoma X glioma NG108-15 hybrid cells after chronic opiate treatment. A multiple-step process.
    Law PY; Hom DS; Loh HH
    Mol Pharmacol; 1982 Jul; 22(1):1-4. PubMed ID: 6126803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of the role of opioid receptors in the response to cannabimimetic drugs.
    Devane WA; Spain JW; Coscia CJ; Howlett AC
    J Neurochem; 1986 Jun; 46(6):1929-35. PubMed ID: 3009717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins.
    Prather PL; Loh HH; Law PY
    Mol Pharmacol; 1994 May; 45(5):997-1003. PubMed ID: 8190115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
    Selley DE; Breivogel CS; Childers SR
    Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE.
    Allouche S; Polastron J; Hasbi A; Homburger V; Jauzac P
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):71-8. PubMed ID: 10432302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of phosducin on opioid receptor function.
    Schulz R; Wehmeyer A; Schulz K; Murphy J
    J Pharmacol Exp Ther; 1999 Apr; 289(1):599-606. PubMed ID: 10087055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine prevents and reverses the expression of chronic etorphine-induced sensitization of adenylyl cyclase in SK-N-SH human neuroblastoma cells.
    Thomas JM; Hoffman BB
    J Pharmacol Exp Ther; 1993 Jan; 264(1):368-74. PubMed ID: 8380866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.